Evaluation of the analgesic effect of Pregabalin in post surgery patient

Evaluation of the analgesic effect of Pregabalin in post Dacryo Cysto Rhinostomy (DCR) Pain Management

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201102185857N1

Enrollment

Registered

2012-01-21

Start date

2010-03-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia. -

Interventions

Intervention 1: Patients in pregabalin group had taken oral pregabalin (300) mg one hour before surgery. Intervention 2: Placebo group received placebo capsules filled with vitamine C.

Treatment - Drugs

Placebo

Patients in pregabalin group had taken oral pregabalin (300) mg one hour before surgery

Placebo group received placebo capsules filled with vitamine C

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-age between 18-60 2-candidated for surgery 3-signing informed consent to enter to this study. Exclusion criteria: 1-history of Hypertension- Diabet Mellitus- Ischemic heart disease- Renal and hepatic disease 2-Addiction 3-ASA or NSAIDS users for a long time

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain mesaured by VAS. Timepoint: At recovery, then 30 min, 2, 4, 12, 24 hours after the surgery. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Nausia and vomiting rate. Timepoint: in the recovery 30 min- 2-4-12-24 hours after the surgery. Method of measurement: asking from the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahzad alimlan

tehran medical university

m-alimian@tums.ac.ir+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026